Home Based Electrical Stimulation on Post-stroke Lower Limb Tightness.
The Feasibility and Impact of A Home-Based NMES Program on Post-Stroke Lower Limb Spasticity
Spasticity is a common complication post stroke. Post-stroke spasticity along with weakness and lack of coordination result in gait abnormalities and functional limitations. Recent treatment option include neuromuscular electric stimulation (NMES), a form of therapy that applies electrical currents to produce contraction of innervated muscle by depolarizing local motor nerves. Currently, there are wide varieties of NMES devices available commercially for consumer.
The main purpose of this study is to evaluate the feasibility and acceptability of a home-based NMES program on lower limb spasticity in patient with post-stroke more than 6 months and to assess the impact of the program. This is single arm prospective intervention study. Patient will apply home-based NMES on their leg for 20 minutes, 5 days a week for 4 weeks. At the end of the study, an outcome measures will be assessed and patient will be required to answer a questionnaires on their experience.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Tze Yang Chung
- Telefonnummer: +60192226593
- E-mail: chungty@ummc.edu.my
Studiesteder
-
-
-
Kuala Lumpur, Malaysia, 59100
- Rekruttering
- University Malaya Medical Center
-
Kontakt:
- Tze Yang Chung
- Telefonnummer: +60192226593
- E-mail: chungty@ummc.edu.my
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Post stroke (hemorrhagic or ischemic) with ankle plantarflexor (gastrocnemius and soleus) spasticity MAS 1+ to MAS 3,
- Post stroke more than 6 months,
- At least 18 years old,
- Able to ambulate 10 meter either independently or aided (single point stick or quadripod)
- Compliant to outpatient therapy.
- Minimal cognitive (MMSE> 24) and minimal sensory impairment,
- Stable neurological and medical condition
Exclusion Criteria:
- Introduction or changes in anti-spastic medication dose within 3 months or during study period,
- Receiving intervention for spasticity (eg BoNT or serial casting) within 3 months or during research period,
- New neurological condition/disease,
- Presence of contraindications to NMES, which is: Pregnancy, Malignancy, Presence of electronic implant eg cardiac pacemaker, cardioverter defibrillator, Uncontrolled seizure/epilepsy, Infected tissues/ tuberculosis or osteomyelitis, Impaired lower limb circulation/ DVT/ thrombophlebitis, Recent fracture or osteoporosis, Actively bleeding tissue or person with untreated hemorrhagic disorder, Damaged or skin diseases at the affected lower limb
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Home-based Electrical Stimulation Program for lower limb spasticity
Single arm prospective intervention study to assess the feasibility and impact of a home-based program.
Patient will apply home-based NMES on their leg for 20 minutes, 5 days a week for 4 weeks.
At the end of the study, an outcome measures will be assessed and patient will be required to answer a questionnaires on their experience.
|
Home-based NMES program on spastic leg. The NMES pre-programmed dosage (locked): NMES waveform is biphasic PC, Frequency 50Hz, pulse width 400µs, ON:OFF 10s:20s and current amplitude: individual maximum tolerated to achieve ankle dorsiflexion.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Retention Rate
Tidsramme: 4 weeks
|
The proportion of patients who completed the program.
Patient completed divided with patient recruited, expressed in percentage (%).
|
4 weeks
|
|
Acceptability
Tidsramme: 4 weeks
|
Acceptability as evaluated at the end of the intervention by brief structured questionnaire developed for this study using 5 point Likert scale with 1 (strongly agree) and 5 (strongly agree).
|
4 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Clinical measurement of spasticity
Tidsramme: 4 weeks (pre and post assessment)
|
Ankle dorsiflexor (gastroc) Modified Ashworth Scale (MAS) as measured in MAS grade 1, 1+, 2, 3, 4
|
4 weeks (pre and post assessment)
|
|
Clinical measurement of spasticity
Tidsramme: 4 weeks (pre and post assessment)
|
Modified Tardieu Scale (R1 and R2 angle of ankle dorsiflexion)
|
4 weeks (pre and post assessment)
|
|
Ankle dorsiflexion muscle strength
Tidsramme: 4 weeks (pre and post assessment)
|
Manual Muscle Testing as measured in 0-5 (with 0 no movement and 5 is the strongest)
|
4 weeks (pre and post assessment)
|
|
Functional Outcome
Tidsramme: 4 weeks (pre and post assessment)
|
10 meter walking test
|
4 weeks (pre and post assessment)
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Raja Nabila BT Raja Mohamed Anuar, University Malaya Medical Center
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2020427-8560
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .